STOCK TITAN

Reliance Global Group Inc 8-K Filings

RELI NASDAQ

Every 8-K that Reliance Global Group Inc (RELI) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 8-K covers material events a company has to report between its quarterly reports, so if you follow RELI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RELI filings page.

Rhea-AI Summary

Reliance Global Group, Inc. has regained compliance with Nasdaq’s continued listing rules after its stock met the exchange’s minimum bid price requirement. Nasdaq confirmed that the company’s common stock closed at or above $1.00 per share for 10 consecutive business days from May 18, 2026 through June 1, 2026, resolving a prior deficiency notice issued in December 2025. The company remains listed on the Nasdaq Capital Market and highlighted ongoing efforts to expand its Insurtech platforms and EZRA International Group while pursuing long-term shareholder value.

Rhea-AI Summary

Reliance Global Group, Inc. approved and implemented a 1-for-40 reverse stock split of its common stock to help regain compliance with Nasdaq’s $1.00 minimum bid price requirement. The amendment to the articles of incorporation is scheduled to become effective at 5:00 p.m. Eastern on May 15, 2026.

Every 40 existing shares will convert into one share, reducing the amount of common stock outstanding from approximately 22,230,563 shares to 555,764 shares, while authorized common shares will be set at 50 million and par value stays at $0.086 per share. Trading on a split-adjusted basis on the Nasdaq Capital Market under the symbol EZRA and new CUSIP 75946W504 is expected to begin on May 18, 2026, with each shareholder’s ownership percentage remaining the same.

Rhea-AI Summary

Reliance Global Group, Inc. reported results from its 2026 Annual Meeting of Stockholders, held via live webcast. As of March 5, 2026, there were 21,253,013 common shares outstanding and entitled to vote, and 9,591,634 shares were represented, about 45.13% of those eligible.

Stockholders elected five directors to serve until the 2027 annual meeting and ratified Urish Popeck & Co., LLC as independent auditor for the year ending December 31, 2026. Each director nominee received over 3.27 million votes for, with substantial broker non-votes.

Investors also approved an amendment to the 2025 Equity Incentive Plan, increasing shares available for issuance by 14,000,000, from 2,000,000 to 16,000,000. In a separate proposal, stockholders approved issuing common shares in excess of the Nasdaq Exchange Cap under a Common Stock Purchase Agreement dated August 26, 2025, as amended.

Rhea-AI Summary

Reliance Global Group formed LifeSci Global Group LLC, a majority-owned healthcare investment vehicle, and funded it using a Promissory Note of up to $2,000,000 from its subsidiary EZRA International Group.

LifeSci Global agreed to purchase up to 421,053 Innervate Radiopharmaceuticals units at $4.75 per unit, totaling about $2.0 million, with $500,000 funded at closing. The deal includes priority distributions and up to 210,526 warrants and was approved by independent directors as a related-party transaction, with committee reshuffling to ensure board independence.

Rhea-AI Summary

Reliance Global Group, Inc. entered into two settlement agreements to resolve disputes tied to prior stock purchase transactions. The company will pay a cash settlement of $90,560 under the Rubin Settlement Agreement and $40,350 under the Kreindler Settlement Agreement, after which all related obligations are fully released.

The company also amended its Common Stock Purchase Agreement with White Lion Capital to extend the investment commitment period through the earlier of reaching the commitment amount or December 31, 2028, and increased the commitment amount to $50,000,000. In addition, Reliance Global Group adopted amended and restated bylaws to give the board flexibility in setting annual meeting dates and filed Articles of Restatement that restate its articles of incorporation in full.

Rhea-AI Summary

Reliance Global Group, Inc. reported that its Board Compensation Committee approved a one-time cash bonus for Chief Financial Officer Joel Markovits. On March 2, 2026, the Committee granted Mr. Markovits a $50,000 gross cash award, which will be paid subject to standard tax withholding and authorized deductions.

Rhea-AI Summary

Reliance Global Group has completed the initial closing of its strategic acquisition of Enquantum Ltd., a post-quantum cryptography company. At closing, Reliance acquired an equity stake representing approximately 8% of Enquantum’s fully diluted share capital through conversion of a previously issued $166,000 secured bridge note and an additional cash investment.

The share purchase agreement is structured as milestone-based tranches that are designed to increase Reliance’s ownership to 51% on a fully diluted basis, subject to specified operational and commercialization milestones and other conditions. A new amendment gives Reliance the right, at its sole discretion, to accelerate funding of one or more tranches even if the related milestones have not yet been met.

Reliance also agreed it may later issue up to $125,000 of its common stock as “Top-Up Shares” to raise its Enquantum stake from 48% to 51% on a fully diluted basis. Enquantum shares issued to Reliance were placed offshore under Regulation S and/or Section 4(a)(2), and any Top-Up Shares are expected to rely on Section 4(a)(2) and/or Regulation D. Reliance’s CEO, Ezra Beyman, has joined Enquantum’s board under the agreement’s governance terms as Reliance seeks to build Enquantum into a core post-quantum cybersecurity platform.

Rhea-AI Summary

Reliance Global Group, Inc. entered into a definitive Share Purchase Agreement to acquire, over time, a 51% fully diluted controlling interest in post-quantum cybersecurity company Enquantum Ltd. for an aggregate purchase price of $2,125,000, paid in milestone-based tranches over about 10 months.

At the initial closing, Reliance expects to obtain an 8% fully diluted stake, including conversion of a previously issued $166,000 bridge note and a cash-funded share issuance. Subsequent monthly tranches are generally structured to increase ownership by 4% per month up to 48%, followed by a final “control top-up” from 48% to 51%.

As part of the control top-up, Reliance has agreed to issue Enquantum common stock valued at $125,000, based on the last reported Nasdaq sale price before the relevant closing, and does not expect to receive cash proceeds from these shares. Reliance plans to hold board control upon achieving specified milestones and to develop Enquantum within its EZRA International Group and Scale51 operating strategy.

Rhea-AI Summary

Reliance Global Group, Inc. filed Amendment No. 3 to its prospectus supplement, allowing ongoing at-the-market sales of common stock with an aggregate offering price of up to $1,764,443 under its existing agreement with H.C. Wainwright & Co., LLC as manager.

The amendment updates and supplements the company’s Form S-3 shelf registration and earlier prospectus supplements. Reliance Global Group has already offered and sold $2,343,660 of common stock under Form S-3 General Instruction I.B.6 during the 12-month period ending on the amendment date. A legal opinion from Zarif Law Group P.C. on the validity of the shares is included as an exhibit.

Rhea-AI Summary

Reliance Global Group, Inc. closed a public equity offering, raising approximately $2.0 million in gross proceeds. The company sold 7,407,408 shares of common stock, or pre-funded warrants in lieu of shares, together with common warrants, at a combined price of $0.27 per share or $0.269 per pre-funded warrant.

Each share or pre-funded warrant was sold with two common warrants, which are immediately exercisable at $0.27 per share and expire two years after initial exercise. H.C. Wainwright & Co. acted as exclusive placement agent and received cash fees, expense reimbursement, and placement agent warrants. Officers, directors, and the company agreed to short-term lock-up and issuance restrictions, and the company plans to use net proceeds for working capital, M&A strategies, and general corporate purposes.

Rhea-AI Summary

Reliance Global Group, Inc. entered into a secured convertible promissory note with Enquantum Ltd., under which Reliance advanced $166,000 to Enquantum as the principal amount. The note bears interest at 1% per year, with default interest at the greater of 10% annually or the maximum allowed under Florida usury laws.

If the parties sign definitive agreements for a contemplated strategic transaction within 30 days of the note date, the debt will be repaid by crediting it against milestone-related payments owed by Reliance, with half applied to the first payment and half to the second. If no definitive agreements are signed in that period (unless extended by written consent), the debt becomes payable in cash within 60 days after the exclusivity period ends.

As security, Enquantum granted Reliance a first-ranking floating charge over substantially all of Enquantum’s present and future assets, including intellectual property, and agreed to negative pledge and disposal restrictions. The note is tied to a non-binding term sheet, and there is no assurance a strategic transaction will be completed.

Rhea-AI Summary

Reliance Global Group, Inc. disclosed that it received a Nasdaq notice on December 12, 2025 stating that its common stock no longer meets the Nasdaq Capital Market’s $1.00 minimum bid price requirement. This notification does not immediately affect the stock’s listing or trading under the symbol RELI.

The company has 180 calendar days, until June 10, 2026, to regain compliance. If its closing bid price is at least $1.00 per share for ten consecutive business days during this period, Nasdaq will confirm compliance and close the matter. If the company still does not meet the bid price rule but satisfies other Nasdaq listing standards, it may qualify for an additional 180-day compliance period if it notifies Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split.

The company states there can be no assurance it will regain compliance and is evaluating possible actions in response to the Nasdaq notice.

Rhea-AI Summary

Reliance Global Group, Inc. entered into a six-month Advisory Agreement with Convergence Strategy Partners, LLC to support its digital asset treasury program and related blockchain and capital markets initiatives. As compensation for these strategic advisory services, the company agreed to issue 450,000 shares of common stock to the Advisor or its designee, with 135,000 shares subject to forfeiture if certain termination conditions occur.

The Advisor will cause its president, Blake Janover, to serve as Chairperson of Reliance Global’s Crypto Advisory Board, formalizing oversight of its digital asset strategy. The Advisory Shares are being issued in a private transaction that has not been registered under the Securities Act and is being made in reliance on Section 4(a)(2) and/or Regulation D, with no underwriters or commissions involved. The company also furnished a press release detailing Janover’s appointment and the digital asset strategy.

Rhea-AI Summary

Reliance Global Group, Inc. announced that its Board approved a special cash dividend of $0.03 per share on its outstanding common stock. The dividend is payable on or about December 2, 2025 to stockholders of record as of October 30, 2025. The company notes that any future dividends will be decided by the Board based on financial condition, results of operations, capital needs, and other relevant factors.

Reliance Global is also advancing a Digital Asset Treasury initiative. It completed its first purchase of Bitcoin (BTC), building on earlier purchases of Ethereum (ETH) and Cardano (ADA), and subsequently completed a purchase of XRP, the native token of the XRP Ledger. These developments were announced through press releases furnished as exhibits to this report.

Rhea-AI Summary

Reliance Global Group, Inc. reported an interim arrangement for cryptocurrency purchases and significant recent unregistered stock issuances. The company entered an Interim Crypto Purchase Agreement with executive Moshe Fishman, allowing him, when directed by the Crypto Advisory Board, to use his personal crypto trading accounts temporarily to buy digital assets for the company until an institutional account is opened. All rights, gains and losses from the purchased cryptocurrency belong to the company, with no compensation to Mr. Fishman beyond reimbursement of purchase costs and documented fees, and the agreement ends once assets are moved or on October 30, 2025, unless extended by the Audit Committee.

Since August 1, 2025, the company issued 613,854 unregistered common shares, equal to about 14.1% of the 4,346,054 shares outstanding as of July 30, 2025. These include 53,186 commitment shares to White Lion under an equity line of credit with no cash proceeds, 110,668 shares to Tomchei Shabbos for marketing services valued at $100,000, and 450,000 shares to White Lion at $0.80 per share for gross proceeds of $360,000. The company also furnished a press release about its initial purchase of Ethereum under its Digital Asset Treasury initiative.

Rhea-AI Summary

Reliance Global Group, Inc. reported that on September 12, 2025, its Compensation Committee accelerated the vesting schedules for certain previously granted restricted stock awards under the 2024 Omnibus Incentive Plan and 2025 Equity Incentive Plan. The Committee stated that these changes are intended to support retention, align management and employees with shareholder value creation, and recognize past contributions.

Awards granted on February 5, 2025 (as amended on February 7, 2025) and July 18, 2025 were amended to vest in full on September 12, 2025 for certain employees and named executive officers. Accelerated awards included 761,775 shares for Chief Executive Officer and Chairman Ezra Beyman, 246,370 shares for Chief Financial Officer Joel Markovits, and 197,399 shares for Executive Vice President, Insurance Division Yaakov Beyman, along with awards held by other employees.